Tutku Zeynep Okyay

Ayass BioScience, LLC was established in 2014 with a mission to provide early disease detection, develop a disease monitoring system, and ultimately achieve better patient outcome by implementing Molecular Modern Medicine to daily clinical practice. We emphasize on Pathophysiology, Genetic, Epigenetic, and Proteomic/Metabolic profiling by conducting comprehensive immunologic testing, and next generation sequencing. Data collection and, more importantly, data interpretation through our bioinformatics and biostatistics department provides meaningful molecular analysis that guides precision medical practices. Our research in the field of Aptamers has opened the door to ground-breaking technology in the fields of both diagnostics and therapeutics. Our goal is to help clinicians implement unique precision medicine in their daily practice. Ayass BioScience, LLC (DBA as Ayass Lung Clinic, PLLC) is a CLIA certified laboratory performing advanced Next Generation Sequencing (Genetic Testing), Cardiac Conditions Hereditary Risk Assessment, Hereditary Cancer Risk Assessment, Neurological Conditions Genetic Predisposition Testing, also COVID-19 Testing (COVID-19 SARS-CoV-2 by RT-PCR), Pharmacogenetic Testing, Allergen Component-Resolved Testing, and Innovative Laboratory Testing. Ayass BioiScience, LLC is working on Aptamers Research and Testing. Ayass BioScience, LLC aims to be at the forefront of latest advancements in precision medicine to provide you with the most effective prevention and treatment options possible.